To determine whether the cognitive improvement observed after microglial Hrh4 deletion were associated with reductions in Aβ and tau pathology, we quantified Aβ plaques in the brains of Lenti–Hrh4–shRNA‐treated aged APP/PS1 and 3xTg‐AD mice. This evidence concerns the gene MAPT and Alzheimer disease.